NFIX and Marinesco-Sjogren syndrome: To identify such novel NFIX downstream target genes that may be misregulated in MSS patients, we chose to initially undertake RNA sequencing and proteomics studies in MEFs because there is reduced genotypic variability in mice generated on the same genetic background compared with fibroblasts derived from unrelated MSS patients, thereby maximizing our chances of identifying statistically significantly altered pathways.